Video
SeaBeLife announces preclinical efficacy results for SBL03 topical ophthalmic gel
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ophthalmic complications observed in patients taking semaglutide and tirzepatide
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Retrospective study finds geographic atrophy can cause 2 to 3 lines of visual acuity loss within 36 months
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children